Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12094-020-02434-3.pdf
Reference92 articles.
1. Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006–2010. Neuro Oncol. 2013;15(2):1–56. https://doi.org/10.1093/neuonc/not151.
2. Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL. Epidemiology of meningiomas post-Public Law. The Benign Brain Tumor Cancer Registries Amendment. Act Cancer. 2015;121(14):2400–10. https://doi.org/10.1002/cncr.29379 (Epub 2015 Apr 14).
3. Kuratsu J, Kochi M, Ushio Y. Incidence and clinical features of asymptomatic meningiomas. J Neurosurg. 2000;92(5):766–70.
4. Håberg AK, Hammer TA, Kvistad KA, Rydland J, Müller TB, Eikenes L, et al. Incidental Intracranial Findings and Their Clinical Impact; the HUNT MRI study in a general population of 1006 participants between 50–66 Years. PLoS ONE. 2016;11(3):15–80.
5. Nakasu S, Hirano A, Shimura T, Llena JF. Incidental meningiomas in autopsy study. Surg Neurol. 1987;27(4):319–22.
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Predicting histological grade in symptomatic meningioma by an objective estimation of the tumoral surface irregularity;Neurocirugía (English Edition);2024-05
2. Predicción del grado histológico en meningiomas sintomáticos mediante una estimación objetiva de la irregularidad de su superficie;Neurocirugía;2023-11
3. Clinical Efficacy of Adjuvant Radiotherapy for World Health Organization Grade II Intracranial Meningioma;World Neurosurgery;2023-07
4. Evidence for external beam radiotherapy in mediastinal Hodgkin and non-Hodgkin lymphoma – systematic review;Annals of Agricultural and Environmental Medicine;2023-06-26
5. The Role of Immunotherapy in the Treatment of Rare Central Nervous System Tumors;Current Oncology;2023-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3